ImmunoGen licenses novel camptothecin ADC platform to Lilly for up to $1.7bn
ImmunoGen will receive $13m in upfront payment for initial targets and is eligible to receive an additional $32.5m…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Feb 22
ImmunoGen will receive $13m in upfront payment for initial targets and is eligible to receive an additional $32.5m…
16 Feb 22
The company will establish new subsidiaries in Malaysia, Taiwan, Singapore, and Hong Kong, to scale up its mRNA…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
15 Feb 22
The agreement follows the US government’s initial deal for 700,000 doses of Evusheld, which are already being administered…
15 Feb 22
The TriNetra-Prostate is a circulating tumour cell detection blood test that identifies early-stage prostate cancer in men aged…
14 Feb 22
According to pseudovirus and authentic virus data, bebtelovimab has shown neutralisation activity against widely circulating variant of concern,…
11 Feb 22
The US drugmaker has used several insights from the CytoReason’ platform, in several of its R&D programmes across…
11 Feb 22
The investigational Covid-19 drug, bebtelovimab, has shown to maintain binding and neutralising activity across currently known and reported…
10 Feb 22
When it comes to the benefits of probiotics, there is much to discover. We speak to consultant Dr…
10 Feb 22
The investment round, jointly led by SoftBank Vision Fund 2 and RA Capital Management, will advance the company’s…
10 Feb 22
Gentis offers specialised DNA testing services, including obstetrical genetics, genealogical DNA tests, oncology, and Covid-19 testing services